Anti-Collagen ADCC Enhanced Antibody (MT293) is an ADCC enhanced antibody produced by our Afuco™ platform. MT293 also known as TRC093, is being developed in a phase 1 clinical trial for the treatment of patients with cancer.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-228 | Recombinant Anti-Collagen Antibody | WB, FC, FuncS | IgG |
MHH-228 | Recombinant Human Anti-Collagen Antibody | WB, Dot, FuncS | IgG |
MOB-0299MZ | Recombinant Mouse Anti-Human Collagen IV Antibody (clone DIV 23 (2)) | IHC | Mouse antibody |
HPAB-1166WJ | Human Anti-Collagen Recombinant Antibody (clone HUIV26) | ELISA, IF, DB, Inhib | Humanized IgG |
HPAB-1167WJ | Human Anti-Collagen Recombinant Antibody (clone HUI77) | ELISA, Inhib | Humanized IgG |
There are currently no Customer reviews or questions for AFC-172CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.